Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan I Moliva

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|April 21, 2017
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against <i>Mycobacterium tuberculosis</i>?Juan I Moliva, Joanne Turner, Jordi B Torrelles
Vaccine|August 31, 2015
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Juan I Moliva, Joanne Turner, Jordi B Torrelles
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2019
Identification of an Increased Alveolar Macrophage Subpopulation in Old Mice That Displays Unique Inflammatory Characteristics and Is Permissive to <i>Mycobacterium tuberculosis</i> InfectionWilliam P Lafuse, Murugesan V S Rajaram, Qian Wu, et al.
The Journal of Infectious Diseases|March 10, 2015
Lung Mucosa Lining Fluid Modification of Mycobacterium tuberculosis to Reprogram Human Neutrophil Killing MechanismsJesús Arcos, Lauren E Diangelo, Julia M Scordo, et al.
Mucosal Immunology|February 20, 2019
Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosisJuan I Moliva, Austin P Hossfeld, Sabeen Sidiki, et al.
Frontiers in Immunology|April 1, 2021
Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human PrimatesHadar Marcus, Emily Thompson, Yan Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2024
Design of universal Ebola virus vaccine candidates via immunofocusingDuo Xu, Abigail E Powell, Ashley Utz, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2022
Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancerNiannian Ji, Meijun Long, Andreu Garcia-Vilanova, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Design of universal Ebola virus vaccine candidates <i>via</i> immunofocusingDuo Xu, Abigail E Powell, Ashley Utz, et al.
Cell Reports|April 8, 2022
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include OmicronHye Kyung Lee, Ludwig Knabl, Juan I Moliva, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|April 21, 2017
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against <i>Mycobacterium tuberculosis</i>?Juan I Moliva, Joanne Turner, Jordi B Torrelles
Vaccine|August 31, 2015
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Juan I Moliva, Joanne Turner, Jordi B Torrelles
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2019
Identification of an Increased Alveolar Macrophage Subpopulation in Old Mice That Displays Unique Inflammatory Characteristics and Is Permissive to <i>Mycobacterium tuberculosis</i> InfectionWilliam P Lafuse, Murugesan V S Rajaram, Qian Wu, et al.
The Journal of Infectious Diseases|March 10, 2015
Lung Mucosa Lining Fluid Modification of Mycobacterium tuberculosis to Reprogram Human Neutrophil Killing MechanismsJesús Arcos, Lauren E Diangelo, Julia M Scordo, et al.
Mucosal Immunology|February 20, 2019
Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosisJuan I Moliva, Austin P Hossfeld, Sabeen Sidiki, et al.
Frontiers in Immunology|April 1, 2021
Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human PrimatesHadar Marcus, Emily Thompson, Yan Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2024
Design of universal Ebola virus vaccine candidates via immunofocusingDuo Xu, Abigail E Powell, Ashley Utz, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2022
Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancerNiannian Ji, Meijun Long, Andreu Garcia-Vilanova, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Design of universal Ebola virus vaccine candidates <i>via</i> immunofocusingDuo Xu, Abigail E Powell, Ashley Utz, et al.
Cell Reports|April 8, 2022
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include OmicronHye Kyung Lee, Ludwig Knabl, Juan I Moliva, et al.
Pageof 4